Dr. David L. Cooper, PhD, MD, Medosi Medical Advisor, publishes: Primer for Seniors: CBD toxicity and potential drug-drug interactions for Medosi’s Corporate clients and customers.
Dr Cooper reviews Medosi’s natural hemp cannabinoids vs. synthetic and biological pharmaceuticals for safety and efficacy.
Included is a detailed look at the Therapetuic Ratio and Safety Comparison of Cannabis to common OTC and prescription drugs used by the elderly.
PhytoDental Solutions (“PDS”) is dedicated to developing phytocannabinoid-based and augmented formulations for
applications across the spectrum of dental diseases and surgical procedures, to provide patients with products
of special effect for daily oral care, and at the same time, introducing advanced technology to build a system
of precision dentistry to systematically solve the long-standing pain points in the dental and health management
industries.
PDS provides a series of professional and consumer products including clinically and statistically validated
indication specific formulation products for dental anxiety, denture stomatitis, orthodontic caries and
gingivitis, periodontitis, peri-implantitis, pre-, post- dental surgical care, and anti-inflammatory consumer
products including toothpaste, dental floss, mouthwash and a series of dental appliances for home use.
PDS indication special formulations are capable of forming a powerful supplement or even replacement for the
obvious clinical defects of most products in the dental market.
By promoting the precise application of cannabinoids in dentistry to block the common "oral entrance of
pathogens", the systemic health of patients is improved, and an innovative new model of health management -
"Dental Health is Well Health" created.
